AMBALALSAPharmaceuticals
Ambalal Sarabhai Enterprises Ltd — Quarterly Results & Earnings
₹24.27
-4.23%
Profit Growth YoY-121.37%Latest quarter
Sales Growth YoY-0.56%Latest quarter
Sales CAGR 5Y8.08%5 year compound
Profit CAGR 5Y-8.94%5 year compound
📋
Quarterly Performance
YoY Profit Growth-121.37%
🔴 Significant decline
YoY Sales Growth-0.56%
⚠️ Mild contraction
OPM 5Y Average
5.24%Operating profit margin
EPS Growth 5Y
-8.94%Interest Coverage
4.87Higher = safer debt servicing
ROE
6.25%ROCE
9.12%💡
Growth Analysis
Ambalal Sarabhai Enterprises Ltd reported YoY profit growth of -121.37% and revenue growth of -0.56% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 8.08% and profits at -8.94% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Ambalal Sarabhai Enterprises Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.